Latest articles

DNA of an award-winning deal

The eligibility requirements for the best venture capital deal in Belgium's life sciences sector, as announced at the 2026 M&A Awards Gala.

How W&I is unlocking Belgian buy-and-build consolidation

Tailored W&I structures and synthetic warranties are changing the M&A landscape for Belgian entrepreneurs selling to private equity-backed consolidators, helping founders achieve a clean exit while maintaining deal certainty and transaction momentum.

Margot Desseyn: M&A is a people’s business

KooKoo co-founder Margot Desseyn fell in love with dealmaking because of the people; now she brings them together to discuss the strategies behind making these deals a success, and will join the M&A Community Belgium on 24 September 2026 in Antwerp to do it again.

Carve-outs give management a real opportunity to lead

During a recent M&A Community Belgium event, Syntagma Capital advisory board member and VIU founder Rudi Nerinckx revealed the top priorities on a carve-out HR agenda; from competency audits and TSAs to value creation plans.

Colruyt Group sells 70 percent of Smart Innovation

Third-generation Belgian family business Colruyt Group has sold 70 percent of its research and development activities related to self-driving pallet trucks to supply chain solutions company KION.

BTL and Medisoft make it official with merger

The UK-based medical equipment developer and manufacturer, BTL Industries, has acquired Belgian company Medisoft, marking its official entry into the respiratory and pulmonary diagnostics space.

Etherna acquisition to evolve targeted RNA treatment

Valerio Therapeutics has signed a binding offer to acquire 100% of the share capital and voting rights of Belgian biotech company Etherna for an enterprise value of €30 million, subject to customary adjustments.

Visiblie raises €500,000 in recent funding round

Belgian start-up Visiblie has raised €500,000 through a convertible loan funding round that includes investors such as Seeder Fund, BeAngels and technology entrepreneur Steven Tielemans.

Gimv sells its stake in AlpenBlu Clinics

Private equity firm Gimv has sold its majority stake in AlpenBlu Clinics, a leading Swiss outpatient mental healthcare provider, to Impact Healthcare (IHC), the healthcare investment platform of Swiss family-owned group Après-Demain.

Prayon to acquire Colombian food ingredients producer HRA

Prayon, a global leader in phosphorus chemistry, has signed a binding agreement to acquire HRA (HRA Uniquímica and HRA Ingredients), a Colombian producer of phosphates, propionates, minerals, and other food sector ingredients.

Quanteus Group: Investing with impact – a conversation with Joachim Vansanten

Joachim Vansanten, Partner at Quanteus Group, believes that it’s possible to generate profit and create impact without compromising on either. With a hands-on approach, a strong focus on impact, and a long-term vision, the investment firm distinguishes itself in a market often dominated by short-term thinking.

New study by BDO-Pavlov examines the role of intangible assets in M&A deals

Why do some acquisitions create lasting value while others fail to deliver on expectations? According to brand strategist and author Stef Verbeeck, (BDO Pavlov) part of the answer may lie in factors that are often overlooked during the deal process: brand strategy, company culture, customer experience and other intangible assets.

Top